BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

369 related articles for article (PubMed ID: 26916898)

  • 1. Stated Preference for Cancer Screening: A Systematic Review of the Literature, 1990-2013.
    Mansfield C; Tangka FK; Ekwueme DU; Smith JL; Guy GP; Li C; Hauber AB
    Prev Chronic Dis; 2016 Feb; 13():E27. PubMed ID: 26916898
    [TBL] [Abstract][Full Text] [Related]  

  • 2. What are GPs' preferences for financial and non-financial incentives in cancer screening? Evidence for breast, cervical, and colorectal cancers.
    Sicsic J; Krucien N; Franc C
    Soc Sci Med; 2016 Oct; 167():116-27. PubMed ID: 27619755
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effect of presenting information about invasive follow-up testing on individuals' noninvasive colorectal cancer screening participation decision: results from a discrete choice experiment.
    Benning TM; Dellaert BG; Severens JL; Dirksen CD
    Value Health; 2014 Jul; 17(5):578-87. PubMed ID: 25128051
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Attributes Used for Cancer Screening Discrete Choice Experiments: A Systematic Review.
    Hall R; Medina-Lara A; Hamilton W; Spencer AE
    Patient; 2022 May; 15(3):269-285. PubMed ID: 34671946
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Eliciting population preferences for mass colorectal cancer screening organization.
    Nayaradou M; Berchi C; Dejardin O; Launoy G
    Med Decis Making; 2010; 30(2):224-33. PubMed ID: 19692710
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A Systematic Review of Discrete Choice Experiments and Conjoint Analysis on Genetic Testing.
    Ozdemir S; Lee JJ; Chaudhry I; Ocampo RRQ
    Patient; 2022 Jan; 15(1):39-54. PubMed ID: 34085205
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Attributes in stated preference elicitation studies on colorectal cancer screening and their relative importance for decision-making among screenees: a systematic review.
    Brinkmann M; Fricke LM; Diedrich L; Robra BP; Krauth C; Dreier M
    Health Econ Rev; 2022 Sep; 12(1):49. PubMed ID: 36136248
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Colorectal Cancer Screening: Preferences, Past Behavior, and Future Intentions.
    Mansfield C; Ekwueme DU; Tangka FKL; Brown DS; Smith JL; Guy GP; Li C; Hauber B
    Patient; 2018 Dec; 11(6):599-611. PubMed ID: 29740804
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An empirical comparison of methods for analyzing correlated data from a discrete choice survey to elicit patient preference for colorectal cancer screening.
    Cheng J; Pullenayegum E; Marshall DA; Marshall JK; Thabane L
    BMC Med Res Methodol; 2012 Feb; 12():15. PubMed ID: 22348526
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Preferences of Iranian average risk population for colorectal cancer screening tests.
    Ramezani Doroh V; Delavari A; Yaseri M; Emamgholipour Sefiddashti S; Akbarisari A
    Int J Health Care Qual Assur; 2019 May; 32(4):677-687. PubMed ID: 31111783
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Eliciting Preferences in Dentistry with Multiattribute Stated Preference Methods: A Systematic Review.
    Barber S; Pavitt S; Khambay B; Bekker H; Meads D
    JDR Clin Trans Res; 2018 Oct; 3(4):326-335. PubMed ID: 30931788
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Assessing stated preferences for colorectal cancer screening: a critical systematic review of discrete choice experiments.
    Wortley S; Wong G; Kieu A; Howard K
    Patient; 2014; 7(3):271-82. PubMed ID: 24652475
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Contextual factors associated with uptake of breast and cervical cancer screening: A systematic review of the literature.
    Plourde N; Brown HK; Vigod S; Cobigo V
    Women Health; 2016; 56(8):906-25. PubMed ID: 26812962
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Demand for Cancer Screening Services: Results From Randomized Controlled Discrete Choice Experiments.
    Bilger M; Özdemir S; Finkelstein EA
    Value Health; 2020 Sep; 23(9):1246-1255. PubMed ID: 32940243
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identifying the barriers to effective breast, cervical and colorectal cancer screening in thirty one European countries using the Barriers to Effective Screening Tool (BEST).
    Priaulx J; de Koning HJ; de Kok IMCM; Széles G; McKee M
    Health Policy; 2018 Nov; 122(11):1190-1197. PubMed ID: 30177278
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Measuring patient preferences for colorectal cancer screening using a choice-format survey.
    Marshall DA; Johnson FR; Phillips KA; Marshall JK; Thabane L; Kulin NA
    Value Health; 2007; 10(5):415-30. PubMed ID: 17888107
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Preferences for colorectal cancer screening techniques and intention to attend: a multi-criteria decision analysis.
    Hummel JM; Steuten LG; Groothuis-Oudshoorn CJ; Mulder N; Ijzerman MJ
    Appl Health Econ Health Policy; 2013 Oct; 11(5):499-507. PubMed ID: 23979875
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interventions to increase breast and cervical cancer screening uptake among rural women: a scoping review.
    Atere-Roberts J; Smith JL; Hall IJ
    Cancer Causes Control; 2020 Nov; 31(11):965-977. PubMed ID: 32840707
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Preferences for interventions designed to increase cervical screening uptake in non-attending young women: How findings from a discrete choice experiment compare with observed behaviours in a trial.
    Campbell HE; Gray AM; Watson J; Jackson C; Moseley C; Cruickshank ME; Kitchener HC; Rivero-Arias O
    Health Expect; 2020 Feb; 23(1):202-211. PubMed ID: 31659850
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Survival or Mortality: Does Risk Attribute Framing Influence Decision-Making Behavior in a Discrete Choice Experiment?
    Veldwijk J; Essers BA; Lambooij MS; Dirksen CD; Smit HA; de Wit GA
    Value Health; 2016; 19(2):202-9. PubMed ID: 27021754
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.